| 2022-02-04 |
|
|
|
External link to document |
| 2022-02-03 |
1 |
Complaint |
#: 2
’721 patent”); U.S. Patent No. 10,167,291 (“the ’291 patent”); and U.S. Patent No. 10,272,083…to the ’504 patent, the ’524
patent, the ’721 patent, the ’291 patent, and the ’083 patent and was seeking…that the ’504 patent, the ’524
patent, the ’721 patent, the ’291 patent, and the ’083 patent will not be…of U.S. Patent No. 9,290,504 (“the ’504 patent”); U.S. Patent No. 9,758,524 (“the
’524 patent”); U.S.…U.S. Patent No. 10,239,883 (“the ’883 patent”); U.S. Patent No. 9,796,721 (“the
|
External link to document |
| 2022-02-04 |
4 |
Patent/Trademark Report to Commissioner of Patents |
,758,524 ;10,239,883 ;9,796,721 ;10,167,291. (mal) (Entered: 02/07/2022)
4 February 2022
PACER…Acerta Pharma B.V. & AstraZeneca UK Limited
5 10,167,291 1/1/2019 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,290,504 ;9,758,524…following
G Trademarks or G Patents. ( G the patent action involves 35 U.S.C. § 292.):
DOCKET…SHARP & DOHME
B.V.
PATENT OR DATE OF PATENT
|
External link to document |
| 2022-02-04 |
5 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083. (mal) (Entered: 02…HOLDER OF PATENT OR TRADEMARK
TRADEMARK NO. OR TRADEMARK
1 10,272,083 …following
G Trademarks or G Patents. ( G the patent action involves 35 U.S.C. § 292.):
DOCKET…SHARP & DOHME
B.V.
PATENT OR DATE OF PATENT
… G Other Pleading
PATENT OR DATE OF PATENT
|
External link to document |